cholic acid has been researched along with Diabetes Mellitus, Type 2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, J; Banerjee, U; Bischoff, E; Cayanan, C; Dhamija, S; Fan, A; Guha, M; Herbert, MR; Heyman, RA; Kabakibi, A; Noble, SA; Pinkerton, AB; Rao, TS; Rix, P; Shiau, AK; Siegel, DL; Staszewski, L; Wang, L | 1 |
| Ao, J; Chiba, T; Fujita, N; Iwanaga, T; Kan, M; Kanayama, K; Kanogawa, N; Kanzaki, H; Kato, J; Kato, N; Kishimoto, T; Kiyono, S; Kobayashi, K; Kojima, R; Kondo, T; Koroki, K; Ma, Y; Muroyama, R; Nakagawa, R; Nakamoto, S; Nakamura, M; Ogasawara, S; Saito, T; Sakuma, T; Unozawa, H | 1 |
| Bao, X; Chen, Y; Lin, L; Pan, T; Qian, K; Wang, H; Wang, Z; Xu, M; Yao, P | 1 |
| Bao, X; Qian, K; Yao, P | 1 |
| Cahen, DL; Diamant, M; Groen, AK; Hoekstra, T; Kramer, MH; Muskiet, MH; Nieuwdorp, M; Smits, MM; Tonneijck, L; van Raalte, DH | 1 |
| Bloks, VW; Brufau, G; Burgerhof, HG; Kuipers, F; Murphy, EJ; Romijn, HA; Scheltema, RA; Smelt, GH; Stellaard, F | 1 |
| Bloks, VW; Boverhof, R; Brufau, G; Jonkers, E; Kuipers, F; Murphy, EJ; Prado, K; Stellaard, F | 1 |
| Bettaieb, A; Chouinard, ML; Cummings, BP; Giulivi, C; Graham, JL; Haj, FG; Hansen, F; Havel, PJ; Jelsing, J; Kim, J; Kowala, M; Ma, F; Shibata, N; Stanhope, KL; Vrang, N | 1 |
2 trial(s) available for cholic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.
Topics: Aged; Bile Acids and Salts; Blood Glucose; Chenodeoxycholic Acid; Cholic Acid; Deoxycholic Acid; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Feces; Female; Gallbladder; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Liraglutide; Male; Metformin; Middle Aged; Organ Size; Postprandial Period; Sitagliptin Phosphate; Sulfonylurea Compounds; Ultrasonography; Ursodeoxycholic Acid | 2016 |
Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism.
Topics: Adult; Allylamine; Bile Acids and Salts; Blood Glucose; Cholic Acid; Colesevelam Hydrochloride; Deoxycholic Acid; Diabetes Mellitus, Type 2; Fibroblast Growth Factors; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Signal Transduction | 2010 |
6 other study(ies) available for cholic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5.
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Hydroxyquinolines; Mice; Quinolines; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thiophenes | 2010 |
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.
Topics: Animals; Cholesterol; Cholic Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fibrosis; Fructose; Insulin Resistance; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2022 |
Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery.
Topics: Animals; Cholic Acid; Diabetes Mellitus, Type 2; Glycolipids; Hypoglycemic Agents; Intestinal Mucosa; Liraglutide; Mice; Molecular Docking Simulation; Nanocomposites; Zein | 2023 |
Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
Topics: Administration, Oral; Animals; Blood Glucose; Cholic Acid; Diabetes Mellitus, Type 2; Drug Carriers; Exenatide; Gastrointestinal Tract; Glycated Hemoglobin; Half-Life; Hypoglycemic Agents; Insulin-Secreting Cells; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; Nanoparticles; Permeability; Phosphatidylcholines; Zein | 2020 |
Two time-point assessment of bile acid kinetics in humans using stable isotopes.
Topics: Bile Acids and Salts; Carbon Isotopes; Chenodeoxycholic Acid; Cholic Acid; Deoxycholic Acid; Deuterium; Diabetes Mellitus, Type 2; Female; Humans; Hypertriglyceridemia; Isotope Labeling; Kinetics; Male; Obesity; Radioisotope Dilution Technique; Reference Values; Time Factors | 2010 |
Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats.
Topics: Adipocytes; Animals; Bile Acids and Salts; Body Weight; Cecum; Cholic Acid; Diabetes Mellitus, Type 2; Disease Models, Animal; Eating; Endoplasmic Reticulum Stress; Energy Metabolism; Gammaproteobacteria; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Hepatocytes; Ileum; Insulin; Insulin-Secreting Cells; Lipid Metabolism; Male; Organ Specificity; Rats; Signal Transduction | 2013 |